9783848484294 - biosimilars: biosimilar drug development di dubey, sunil kumar; r. shrivastava, r. (4 risultati)

- Brossura
Da: preigu, Osnabrück, Germaniapreigu
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 43,30
EUR 70,00 spedizioneSpedito da Germania a U.S.A.Quantità: 5 disponibili
Taschenbuch. Condizione: Neu. Biosimilars | Biosimilar Drug Development | Sunil Kumar Dubey (u. a.) | Taschenbuch | Englisch | LAP Lambert Academic Publishing | EAN 9783848484294 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

- Brossura
Da: Mispah books, Redhill, SURRE, Regno UnitoMispah books
Contatta il venditoreVenditore con 4 stelleCondizione: Usato - Come nuovo
EUR 119,87
EUR 28,81 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Paperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

- Brossura
- Print on Demand
Da: moluna, Greven, , Germaniamoluna
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 41,67
EUR 48,99 spedizioneSpedito da Germania a U.S.A.Quantità: Più di 20 disponibili
Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Dubey Sunil KumarAt present, I am working as a lecturer in the Department of Pharmacy, Birla Institute of Science & Technology, Pilani. I have published more than 22 research papers of national and int…ernational repute and presented.

- Brossura
- Print on Demand
Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 49,59
EUR 60,50 spedizioneSpedito da Germania a U.S.A.Quantità: 2 disponibili
Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This review gives clear insight on Biosimilars. Biosimilars the follow-on biologicals is the new area for a pharmaceutical industry to consider whether it suits its expertise, its business interest and offers for it opportunities for gr…owth. This review explores Biosimilar Drug Development from the view-point of a biopharmaceutical company and proposes key points that a company needs to consider through the process of planning biosimilar drug development. It examines significant developments in the biosimilars market and will arm the reader with scientific, regulatory and strategic information needed to face new opportunities as well as the challenges of the biosimilars revolution.